A detailed history of Mathes Company, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Mathes Company, Inc. holds 19,995 shares of JNJ stock, worth $3.11 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
19,995
Previous 20,049 0.27%
Holding current value
$3.11 Million
Previous $2.93 Million 10.58%
% of portfolio
1.14%
Previous 1.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$145.48 - $167.38 $7,855 - $9,038
-54 Reduced 0.27%
19,995 $3.24 Million
Q1 2024

May 02, 2024

SELL
$155.22 - $162.74 $9,623 - $10,089
-62 Reduced 0.31%
20,049 $3.17 Million
Q4 2023

Jan 30, 2024

SELL
$145.6 - $158.88 $18,782 - $20,495
-129 Reduced 0.64%
20,111 $3.15 Million
Q3 2023

Oct 26, 2023

BUY
$155.75 - $174.48 $12,615 - $14,132
81 Added 0.4%
20,240 $3.15 Million
Q2 2023

Jul 25, 2023

SELL
$154.35 - $166.11 $8,489 - $9,136
-55 Reduced 0.27%
20,159 $3.34 Million
Q4 2022

Jan 25, 2023

SELL
$160.2 - $179.79 $7,208 - $8,090
-45 Reduced 0.22%
20,214 $3.57 Million
Q3 2022

Oct 18, 2022

SELL
$161.33 - $179.52 $12,099 - $13,464
-75 Reduced 0.37%
20,259 $3.31 Million
Q2 2022

Aug 01, 2022

SELL
$168.19 - $186.01 $72,321 - $79,984
-430 Reduced 2.07%
20,334 $3.61 Million
Q1 2022

Jun 15, 2022

SELL
$158.14 - $179.59 $142,326 - $161,631
-900 Reduced 4.15%
20,764 $3.68 Million
Q4 2021

Feb 04, 2022

SELL
$155.93 - $173.01 $46,779 - $51,903
-300 Reduced 1.37%
21,664 $3.71 Million
Q3 2021

Oct 29, 2021

SELL
$161.5 - $179.47 $145,350 - $161,523
-900 Reduced 3.94%
21,964 $3.55 Million
Q2 2021

Jul 20, 2021

SELL
$159.48 - $171.07 $98,080 - $105,208
-615 Reduced 2.62%
22,864 $3.77 Million
Q1 2021

Apr 28, 2021

SELL
$153.07 - $170.48 $17,296 - $19,264
-113 Reduced 0.48%
23,479 $3.86 Million
Q4 2020

Jan 20, 2021

BUY
$137.11 - $157.38 $75,410 - $86,559
550 Added 2.39%
23,592 $3.71 Million
Q3 2020

Oct 26, 2020

SELL
$140.38 - $153.83 $217,589 - $238,436
-1,550 Reduced 6.3%
23,042 $3.43 Million
Q2 2020

Jul 27, 2020

SELL
$128.81 - $155.51 $144,267 - $174,171
-1,120 Reduced 4.36%
24,592 $3.46 Million
Q1 2020

Apr 21, 2020

SELL
$111.14 - $153.99 $225,614 - $312,599
-2,030 Reduced 7.32%
25,712 $3.37 Million
Q4 2019

Jan 30, 2020

SELL
$127.5 - $146.44 $87,337 - $100,311
-685 Reduced 2.41%
27,742 $4.05 Million
Q3 2019

Oct 21, 2019

SELL
$126.95 - $142.14 $44,432 - $49,748
-350 Reduced 1.22%
28,427 $3.68 Million
Q2 2019

Jul 29, 2019

SELL
$131.15 - $144.24 $16,393 - $18,030
-125 Reduced 0.43%
28,777 $4.01 Million
Q1 2019

May 01, 2019

SELL
$125.72 - $139.79 $246,411 - $273,988
-1,960 Reduced 6.35%
28,902 $4.04 Million
Q4 2018

Jan 29, 2019

SELL
$122.84 - $147.84 $120,383 - $144,883
-980 Reduced 3.08%
30,862 $3.98 Million
Q3 2018

Oct 31, 2018

SELL
$121.58 - $142.88 $326,442 - $383,632
-2,685 Reduced 7.78%
31,842 $4.4 Million
Q2 2018

Jul 27, 2018

BUY
$119.4 - $131.76 $225,069 - $248,367
1,885 Added 5.77%
34,527 $4.19 Million
Q1 2018

Apr 27, 2018

SELL
$125.1 - $148.14 $467,248 - $553,302
-3,735 Reduced 10.27%
32,642 $4.18 Million
Q4 2017

Jan 19, 2018

BUY
$131.22 - $143.62 $91,854 - $100,534
700 Added 1.96%
36,377 $5.08 Million
Q3 2017

Oct 20, 2017

BUY
$129.47 - $135.38 $4.62 Million - $4.83 Million
35,677
35,677 $4.64 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mathes Company, Inc. Portfolio

Follow Mathes Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mathes Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mathes Company, Inc. with notifications on news.